Palatin Presents Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference Regarding a Potential Treatment for Glaucoma

– Poster presented at ARVO demonstrates PL9588 reduces intraocular pressure – Data provides further support for topical administration of melanocortins for ocular inflammation CRANBURY, N.J., April 25, 2023 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.